Janus Kinase Inhibitor

Janus Kinase Inhibitor
Accession Number

Not Available

DrugDrug Description
TofacitinibA Janus kinase (JAK) inhibitor used to treat rheumatic conditions, such as rheumatoid arthritis and ankylosing spondylitis, and ulcerative colitis.
BaricitinibA Janus kinase inhibitor used to treat moderate to severe rheumatoid arthritis that has responded poorly to at least one TNF antagonist.
AbrocitinibA kinase inhibitor used to treat moderate-to-severe atopic dermatitis in adults.
RuxolitinibA kinase inhibitor used to treat various types of myelofibrosis, polycythemia vera in patients who have not responded to or cannot tolerate hydroxyurea, and to treat graft-versus-host disease in cases that are refractory to steroid treatment.
DeucravacitinibA TYK2 inhibitor being investigated as a treatment for psoriasis.
Drugs & Drug Targets
TofacitinibNon-receptor tyrosine-protein kinase TYK2target
TofacitinibCytochrome P450 3A4enzyme
TofacitinibCytochrome P450 2C19enzyme
TofacitinibTyrosine-protein kinase JAK2target
TofacitinibTyrosine-protein kinase JAK1target
TofacitinibTyrosine-protein kinase JAK3target
TofacitinibSerum albumincarrier
BaricitinibSolute carrier family 22 member 8transporter
BaricitinibATP-binding cassette sub-family G member 2transporter
BaricitinibMultidrug and toxin extrusion protein 2transporter
BaricitinibCytochrome P450 3A4enzyme
BaricitinibTyrosine-protein kinase JAK1target
BaricitinibTyrosine-protein kinase JAK2target
BaricitinibSolute carrier family 22 member 6transporter
BaricitinibSolute carrier family 22 member 2transporter
BaricitinibSolute carrier organic anion transporter family member 1B3transporter
BaricitinibTyrosine-protein kinase JAK3target
BaricitinibP-glycoprotein 1transporter
BaricitinibNon-receptor tyrosine-protein kinase TYK2target
AbrocitinibCytochrome P450 2C19enzyme
AbrocitinibCytochrome P450 2C9enzyme
AbrocitinibCytochrome P450 3A4enzyme
AbrocitinibCytochrome P450 2B6enzyme
AbrocitinibTyrosine-protein kinase JAK1target
AbrocitinibP-glycoprotein 1transporter
AbrocitinibSolute carrier family 22 member 1transporter
AbrocitinibTyrosine-protein kinase JAK2target
AbrocitinibTyrosine-protein kinase JAK3target
AbrocitinibNon-receptor tyrosine-protein kinase TYK2target
AbrocitinibSerum albumincarrier
AbrocitinibSolute carrier family 22 member 8transporter
RuxolitinibTyrosine-protein kinase JAK1target
RuxolitinibTyrosine-protein kinase JAK2target
RuxolitinibCytochrome P450 3A4enzyme
RuxolitinibCytochrome P450 2C9enzyme
RuxolitinibSerum albumincarrier
RuxolitinibTyrosine-protein kinase JAK3target
RuxolitinibNon-receptor tyrosine-protein kinase TYK2target
DeucravacitinibNon-receptor tyrosine-protein kinase TYK2target